| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -18% |
| 3Y CAGR | -3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +1,900% |
| 3Y CAGR | +4% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,688.40 -66.30 (1.77%) | 17,211.67 | 23.41 | 4.1 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,194.70 -26.90 (1.21%) | 16,883.72 | 24.9 | 5.01 | ||
Natco PharmaNATCOPHARM | ₹781.90 -2.55 (0.33%) | 15,397.22 | 13.45 | 1.47 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,009.00 -70.50 (1.16%) | 15,192.25 | 89.56 | 17.41 |